Covered stents in patients with congenital heart defects

Butera, Gianfranco; Piazza, Luciane; Chessa, Massimo; Abella, Raúl; Bussadori, C.; Negura, Diana; Carminati, Mário

doi:10.1002/ccd.20652

Cited by 33 publications

(27 citation statements)

References 20 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Covered stents have been used successfully in the management of aortic coarctation and a number of reports document this experience [117][118][119][120][121][122][123][124][125][126][127][128][129][130][131][132][133][134][135][136] A variety of covered stents have been utilized and these include Jostent grafts (Jomed International, Helsingborg, Sweden), Cheatham-Platinum stents (NuMed Inc, Hopkinton, NY), AneuRx (Medtronic, Watford, UK), Advanta V12 (Atrium Medical, Hudson, NH) and others. While these stents are available outside the United States, they are not approved by the US Food and Drug Administration (FDA) for clinical use.…”

Section: Covered Stentsmentioning

confidence: 99%

Transcatheter Stent Therapy in Children: An Update

Sahu

Rao²

2012

Pediat Therapeut

View full text Add to dashboard Cite

To address elastic recoil of vessel wall and intimal dissection that can follow balloon angioplasty, stents have been designed and these appear to produce more effective relief of obstruction. Of the two types of stents, namely, balloon expandable and self expandable, balloon expandable stents are most commonly used in children. The usefulness of stents in the management of vascular obstructive lesions not amenable to balloon angioplasty is well established and has been successfully used to treat branch pulmonary artery stenosis, coarctation of the aorta, stenotic right ventricular outflow tract conduits, obstructive lesions of the systemic and pulmonary veins and others. The techniques of implantation, indications, immediate and follow-up results and complications were reviewed. The stents have also been effectively used in keeping open naturally occurring or artificially created inter-circulatory connections and as adjuncts in hybrid procedures, but these have not been discussed in this review. Future directions include investigative work on biodegradable stents and growth stents to address issues related to increase in vessel size in infants and children, use of drug eluding stents to prevent neo-intimal proliferation to avoid pulmonary vein restenosis and refinement of stent technology in hybrid procedures such as neonatal palliation of hypoplastic left heart syndrome and transcatheter completion of Fontan procedure. The feasibility, safety and effectiveness stents in the pediatric population are demonstrated, although scrutiny of results of larger experience with longer follow-up is important.

show abstract

Section: Covered Stentsmentioning

confidence: 99%

Transcatheter Stent Therapy in Children: An Update

Sahu

Rao²

2012

Pediat Therapeut

View full text Add to dashboard Cite

show abstract

“…17,18 Caution should be exercised, however, in regard to differing risks attributed to covered stents, including stent thrombosis, in-stent restenosis, and inability to redilate such stents at future settings.…”

Section: Angioplasty Aortic Coarctationmentioning

confidence: 99%

Interventional Catheterization in Adult Congenital Heart Disease

Inglessis

Landzberg

2007

Circulation

View full text Add to dashboard Cite

“…This technique is used in some patients with subatretic coarctation, in which a two-stage approach is advocated. In these cases the balloon dilatation is followed by stent implantation after a few months [7,8] or in the same procedure [9,10]. Our patient had a good result.…”

Section: Discussionmentioning

confidence: 72%

Balloon Angioplasty of Subatretic Coarctation of the Aorta Using Progressive Larger Balloons

Jacob¹,

Faria²

2013

J Clin Exp Cardiolog

View full text Add to dashboard Cite

We report a case of subatretic coarctation of the aorta with dilated ascending aorta in a three-year-old boy weighing 14 Kg. Surgical treatment was indicated, but it was refused. Balloon angioplasty of the coarctation was performed using progressive increase in the diameter of the balloons. The diameters of the balloons ranged from 2 to 10 mm, and the gradient decreased from 60 down to 12 mmHg. We conclude that the balloon angioplasty with careful progressive increase in the balloon diameter is safe in the treatment of subatretic coarctation of the aorta with good results.

show abstract

Covered stents in patients with congenital heart defects

Abstract: Covered Cheatham-Platinum stents are very useful tools for treating various congenital cardiovascular malformations.

Cited by 33 publications

References 20 publications

Transcatheter Stent Therapy in Children: An Update

Transcatheter Stent Therapy in Children: An Update

Interventional Catheterization in Adult Congenital Heart Disease

Balloon Angioplasty of Subatretic Coarctation of the Aorta Using Progressive Larger Balloons

Contact Info

Product

Resources

About